Endoscopy Market Size & Share 2026-2035

Endoscopy Market Size

The global endoscopy market was estimated at USD 31.2 billion in 2025. The market is expected to grow from USD 33.1 billion in 2026 to USD 61.5 billion in 2035, at a CAGR of 7.1% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by numerous factors, such as rising prevalence of chronic and gastrointestinal diseases, growing preference for minimally invasive surgeries (MIS), among other factors.

Endoscopy is a medical process performed by the doctor using an endoscope, a lighted flexible tube fitted with a camera at the tip to observe the internal parts of a patient's body. It enables the physician to view and assess various structures which include lungs, joints and the gastrointestinal tract without making anywhere near as large of an incision as traditional surgery. Typical uses of endoscopy include performing diagnoses, surgical biopsies, and some treatment procedures.

Rising demand for advanced visualization systems is expected to fuel the industry's growth. Olympus Corporation, Stryker Corporation, Karl Storz, Boston Scientific, and Medtronic are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, research and development, and collaboration with local or regional healthcare providers, among other factors.

The endoscopy market has increased from USD 26.5 billion in 2022 and reached USD 29.5 billion in 2024, with a historic growth rate of 5.4%. The prevalence of chronic illnesses such as gastrointestinal disorders, colorectal cancer, and cardiovascular diseases is rising globally. According to the World Health Organization (WHO), cardiovascular diseases accounted for 20.5 million deaths in the year 2021, which is 32% of the total deaths. Similarly, the American Cancer Society estimates around 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer in 2023. In addition, as per the data by CDC, about 22.4 million adults were reported for gastrointestinal disorders in the year 2022. Endoscopy is a pivotal diagnostic and therapeutic procedure for the above problems. The escalating prevalence of such diseases increases the necessity for cost effective procedures to treat and diagnose such conditions, especially for cancer.

Healthcare systems are being developed and improved as governments and private corporations increase their spending. For instance, the U.S. allocated USD 8.5 billion in its 2021 Infrastructure Investment and Jobs Act for the modernization of healthcare facilities in rural areas. These investments seek to purchase contemporary medical equipment, such as endoscopic systems. On top of that, the World Bank granted USD 1.2 billion in 2022 towards training for healthcare practitioners in developing countries, a large part of which is for training of endoscopic procedures.

According to the World Health Organization (WHO), by 2030, 1 in 6 people globally will be aged 60 years or older, with the population increasing from 1 billion in 2020 to 1.4 billion, and expected to reach 2.1 billion by 2050. This demographic shift is significantly increasing the demand for minimally invasive diagnostic techniques such as endoscopy, as elderly patients often require frequent screening, early diagnosis, and ongoing disease monitoring, thereby supporting sustained market growth.

Endoscopy Market Trends

The advancements in endoscope technologies and design innovations play a critical role in driving market growth by improving procedural efficiency, enhancing diagnostic accuracy, and supporting minimally invasive clinical outcomes.

• Advanced endoscopes are increasingly being developed with high-definition (HD) and 4K imaging systems, narrow band imaging (NBI), and fluorescence imaging technologies, which provide superior visualization of internal structures and enable early detection of abnormalities such as tumors, lesions, and bleeding sites. These innovations enhance image clarity, depth perception, and tissue differentiation, thereby improving clinical decision-making and procedural success rates.
• These advancements significantly reduce complications by enabling more precise navigation, improved targeting, and reduced procedure time. Additionally, the integration of robotic-assisted endoscopy, disposable (single-use) endoscopes, and AI-powered diagnostic support systems help minimize infection risks, improve safety, and enhance workflow efficiency. Improvements in flexible design, miniaturization, and ergonomics further support ease of use and patient comfort, while enabling access to hard-to-reach anatomical regions.
• Olympus’s EVIS X1 endoscopy system incorporates advanced imaging technologies such as red dichromatic imaging (RDI) and texture and color enhancement imaging (TXI), enabling improved visualization of bleeding sources and mucosal structures. Similarly, Boston Scientific’s EXALT single-use endoscope platform provides disposable solutions designed to reduce cross-contamination risks while maintaining high imaging performance and procedural reliability.
• Collectively, these technological advancements highlight a strong industry focus on precision, safety, and efficiency, thereby reinforcing innovation in endoscopic systems as a key factor supporting sustained growth in the endoscopy industry.

Endoscopy Market Analysis

Based on product, the endoscopy market is segmented into endoscopes, visualization systems, endoscopic ultrasound, insufflator, and other products. The endoscopes segment accounted for a dominant market share of 49.4% in 2025, driven by its essential role in enabling minimally invasive diagnostic and therapeutic procedures across gastrointestinal, respiratory, and urological applications. The segment is expected to reach USD 31 billion by 2035, growing at a CAGR of 7.4% during the forecast period.

• The endoscopes segment comprises flexible and rigid devices designed to visualize internal organs and cavities using integrated imaging systems. These include gastrointestinal endoscopes, bronchoscopes, ureteroscopes, and duodenoscopes, used for both diagnostic and therapeutic procedures. Endoscopes enable direct visualization, tissue biopsy, and minimally invasive interventions, making them central to modern clinical practice across multiple specialties.
• The segment’s strong growth is driven by increasing demand for minimally invasive procedures, rising prevalence of chronic diseases such as gastrointestinal disorders and cancers, and ongoing technological advancements including high-definition imaging, single-use endoscopes, and enhanced maneuverability.
• Additionally, the adoption of robotic-assisted endoscopy, artificial intelligence (AI)-assisted lesion detection, and capsule-based diagnostic systems is enhancing procedural precision and diagnostic accuracy. The shift toward single-use/disposable endoscopes is further addressing infection control concerns, while advancements in flexibility, miniaturization, and ergonomics are improving access to complex anatomical regions. Collectively, rising demand for minimally invasive procedures, increasing prevalence of chronic diseases, and rapid integration of advanced technologies are reinforcing the continued expansion of the endoscopes segment within the endoscopy market.
• The visualization systems segment is projected to expand at 6.9% CAGR to reach USD 14.4 billion by 2035. Visualization systems consist of components that support the imaging and display capabilities of endoscopic procedures, including cameras, light sources, monitors, video processors, and image enhancement technologies. These systems convert visual input from endoscopes into high-resolution digital images, enabling clinicians to accurately observe internal structures during procedures. Growth in this segment is driven by advancements in imaging technologies such as 4K resolution, narrow band imaging (NBI), and fluorescence imaging, which enhance diagnostic accuracy and enable early detection of abnormalities. Additionally, increasing integration with digital platforms and hospital information systems supports real-time data capture and analysis, further strengthening demand for advanced visualization systems.
• The endoscopic ultrasound segment is projected to expand at 7.6% CAGR to reach USD 4.6 billion by 2035. Endoscopic ultrasound combines endoscopy with ultrasound imaging to provide detailed visualization of internal organs and surrounding tissues, particularly in the gastrointestinal tract and nearby structures such as the pancreas and bile ducts. It is widely used for diagnostic evaluation, staging of cancers, and guided interventions such as fine-needle aspiration (FNA).
• The growth of this segment is supported by increasing demand for precise diagnostic techniques, rising cancer incidence, and the need for minimally invasive guided procedures. Technological improvements in ultrasound imaging quality and integration with therapeutic capabilities are further enhancing the clinical value of endoscopic ultrasound systems.
• The insufflator segment is projected to expand at 6.7% CAGR to reach USD 2.6 billion by 2035. Insufflators are devices used to deliver gas, typically carbon dioxide, into body cavities during endoscopic procedures to expand the area and improve visibility. They are essential in procedures such as laparoscopy and certain gastrointestinal endoscopies, ensuring adequate working space for accurate examination and intervention.
• Demand for insufflators is driven by the increasing volume of minimally invasive procedures and advancements in pressure control and gas flow regulation technologies, which enhance safety and procedural efficiency. The shift toward safer, more patient-friendly insufflation methods, such as CO₂-based systems, is further contributing to segment growth.
• The other products segment including biopsy forceps, snare loops & electrosurgical probes, GI bleed management devices, ablation devices etc. is projected to expand at 6.5% CAGR to reach USD 8.8 billion by 2035. Growth in this segment is driven by increasing procedure volumes, expansion of therapeutic endoscopy applications, and heightened focus on infection prevention and device reprocessing standards. The rising adoption of single-use accessories and improved procedural tools is further enhancing efficiency and supporting overall market expansion.

Based on application, the endoscopy market is segmented into laparoscopy, GI endoscopy, arthroscopy, ENT endoscopy, pulmonary endoscopy, obstetrics/gynecology, and other applications. The GI endoscopy segment is projected to expand at 7.3% CAGR to reach USD 19.6 billion by 2035.

• Gastrointestinal (GI) endoscopy represents the most significant application within the endoscopy industry, encompassing procedures used to diagnose, monitor, and treat conditions affecting the digestive tract, including the esophagus, stomach, small intestine, and colon. The segment also includes advanced modalities such as capsule endoscopy and endoscopic submucosal dissection (ESD), expanding its clinical scope beyond diagnostics into minimally invasive treatment.
• The dominance of the GI endoscopy segment is driven by the rising prevalence of gastrointestinal disorders, including colorectal cancer, inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and gastrointestinal bleeding. Increasing screening programs for colorectal cancer, particularly in developed regions, are significantly boosting procedure volumes, as early detection remains critical for improving survival outcomes. Furthermore, lifestyle-related factors such as aging populations, dietary changes, and increasing incidence of obesity are contributing to a higher burden of GI diseases, thereby strengthening long-term demand.
• Technological advancements are further accelerating growth within this segment, with the integration of high-definition (HD), 4K imaging, narrow band imaging (NBI), capsule endoscopy, and AI-assisted lesion detection systems enhancing diagnostic accuracy and enabling early-stage disease identification. Overall, the combination of increasing disease burden, high screening volumes, and continuous innovation in visualization and therapeutic capabilities reinforces GI endoscopy as the central application segment within the endoscopy market.
• The laparoscopy segment is projected to expand at 6.7% CAGR to reach USD 10.8 billion by 2035. Laparoscopy refers to minimally invasive surgical procedures performed through small incisions using specialized endoscopic instruments and cameras to examine and operate within the abdominal cavity. It is widely used across multiple specialties, including general surgery, urology, and gynecology. Growth in this segment is driven by the increasing demand for minimally invasive surgeries, advantages such as reduced hospital stays and faster recovery, and advancements in laparoscopic instruments, visualization systems, and robotic-assisted technologies, which improve precision and surgical outcomes.
• The arthroscopy segment is projected to expand at 6.3% CAGR to reach USD 5 billion by 2035. Arthroscopy involves the use of endoscopic instruments to diagnose and treat joint-related conditions, particularly in the knee, shoulder, and hip. The procedure allows surgeons to visualize joint structures, repair damaged tissues, and perform minimally invasive interventions. The segment is driven by the rising incidence of sports injuries, increasing prevalence of musculoskeletal disorders, and growing preference for minimally invasive orthopedic procedures. Technological advancements such as high-definition cameras and improved surgical tools are further enhancing procedural efficiency and supporting growth in arthroscopy applications.
• The obstetrics/gynecology segment is projected to expand at 8.1% CAGR to reach USD 9.3 billion by 2035. Endoscopic procedures in obstetrics and gynecology primarily involve hysteroscopy and laparoscopy for the diagnosis and treatment of conditions related to the female reproductive system. These procedures are used for applications such as uterine evaluation, infertility diagnosis, fibroid removal, and treatment of endometriosis. The segment is supported by increasing awareness of women’s health, rising infertility rates, and growing preference for minimally invasive surgical techniques that offer reduced recovery time and improved clinical outcomes.

Based on usability, the endoscopy market is segmented into reusable endoscopes and singleuse endoscopes. The reusable endoscope segment is projected to expand at 6.2% CAGR to reach USD 50.4 billion by 2035.

• The reusable endoscope segment represents the leading category in the endoscopy industry, supported by its long‑established integration into clinical workflows, wide procedural applicability, and significantly lower long‑term cost per use compared to disposable alternatives. Their ability to deliver high‑resolution imaging, incorporate advanced visualization technologies, and accommodate therapeutic tools reinforces their continued preference in high‑volume settings.
• Furthermore, reusable endoscopes continue to benefit from ongoing enhancements in device construction, optical precision, and ergonomic handling. Manufacturers are focusing on improving scope durability, enhancing flexibility for navigating complex anatomy, and integrating smarter control interfaces that streamline workflows for clinicians. The segment is also supported by rising procedural volumes in hospitals and specialty centers, where reusable systems remain the preferred option due to their long operational lifespan and compatibility with a wide range of therapeutic tools. Furthermore, investments in workforce training and standardized reprocessing protocols are enabling healthcare facilities to maintain high-quality performance while optimizing operational efficiency, reinforcing the continued reliance on reusable endoscopic platforms across high-volume care environments.
• The single‑use endoscope segment is projected to expand at 12.9 % CAGR to reach USD 11 billion by 2035. The single‑use endoscope segment is gaining traction driven by rising concerns over cross‑contamination, greater emphasis on infection prevention, and the need to eliminate costly and labor‑intensive reprocessing requirements. Increasing adoption in outpatient facilities, emergency departments, and settings with limited sterilization infrastructure is further enhancing the role of single‑use endoscopes, supporting their expansion across targeted clinical applications.

Based on end use, the endoscopy market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominates the market with a revenue of around USD 18.3 billion in 2025.

• The hospitals segment accounts for the leading share of the endoscopy industry, supported by the large volume of diagnostic and therapeutic procedures conducted within acute‑care settings. Hospitals remain the primary destination for complex endoscopic interventions, including gastrointestinal, respiratory, urological, and surgical applications, owing to the availability of advanced imaging platforms, specialized endoscopy suites, and skilled clinical personnel. Integrated care pathways, multidisciplinary expertise, and access to high‑end capital equipment enable hospitals to deliver comprehensive diagnostic evaluation and minimally invasive treatments, reinforcing the clinical and operational dominance of this segment.
• Additionally, hospitals benefit from strong investment capacity, enabling continuous upgrades in visualization technologies, adoption of robotic‑assisted systems, and expansion of single‑use endoscope portfolios to support infection‑control protocols. Increasing procedure volumes, expanding outpatient capabilities within hospital systems, and the growing emphasis on early disease detection further drive the utilization of endoscopy across high‑acuity care settings. These factors collectively sustain the segment’s leadership position within the market.
• The ambulatory surgical centers segment is projected to expand at 6.9% CAGR to reach USD 15.8 billion by 2035. The ambulatory surgical centers segment is gaining momentum due to the rising shift toward same‑day, minimally invasive procedures that offer faster turnaround times and cost efficiency compared to hospital‑based interventions. ASCs increasingly perform routine endoscopic procedures such as colonoscopy, bronchoscopy, and cystoscopy, supported by streamlined workflows, lower operating costs, and improved patient throughput. Growing preference for outpatient care, payer incentives for cost‑effective procedural settings, and expanding availability of compact, high‑performance endoscopic systems are supporting the adoption of endoscopy within ASCs. The segment benefits from operational flexibility and rising demand for convenient, lower‑cost clinical environments, driving continued market expansion.
• The other end users segment is projected to expand at 5.4% CAGR to reach USD 7.9 billion by 2035. The other end users segment includes specialty clinics, diagnostic centers, and office‑based practices that perform targeted endoscopic evaluations and follow‑up assessments. These facilities primarily focus on routine screenings, early‑stage diagnostics, and ongoing patient monitoring, supported by portable or mid‑range endoscopic equipment. The segment is further supported by growing emphasis on preventive care, improved reimbursement structures, and expanding deployment of single‑use devices that reduce infrastructure and reprocessing requirements, enabling broader adoption beyond traditional hospital environments.

North America Endoscopy Market

The North America endoscopy industry accounted for a majority share of 39.4% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. endoscopy industry was valued at USD 9.5 billion and USD 9.9 billion in 2022 and 2023, respectively. The market size reached USD 10.9 billion in 2025, growing from USD 10.4 billion in 2024, and is anticipated to grow at a CAGR of 6.3% from 2026 to 2035.
• The North America endoscopy market is significantly driven by the high prevalence of gastrointestinal and related disorders across the region, which continues to expand the patient population requiring diagnostic and therapeutic endoscopic interventions. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Centers for Disease Control and Prevention (CDC), digestive diseases affect up to 70 million U.S. population and contribute to over 41 million emergency department visits annually. This substantial disease burden is creating sustained demand for advanced endoscopic procedures such as colonoscopy, gastroscopy, and ERCP, supporting early diagnosis, effective disease management, and improved clinical outcomes across healthcare settings. The increasing need for minimally invasive diagnostic techniques is further reinforcing the adoption of technologically advanced endoscopic systems across North America.
• Furthermore, the steady volume of diagnostic procedures and screening programs continues to support ongoing market demand. The widespread implementation of colorectal cancer screening initiatives, combined with rising awareness regarding early disease detection and preventive healthcare, is driving consistent utilization of endoscopy procedures across hospitals and outpatient settings. Increasing integration of advanced imaging technologies, expansion of ambulatory surgical centers, and growing preference for minimally invasive interventions are further supporting adoption across the region.
• In addition, strong healthcare infrastructure, favorable reimbursement frameworks, and continuous innovation in endoscopic technologies are reinforcing the demand for high‑performance endoscopic solutions, thereby sustaining the overall growth trajectory of the North America endoscopy industry.

Europe Endoscopy Market

Europe accounted for a significant share of the endoscopy industry and was valued at USD 8.2 billion in 2025.

• The Europe endoscopy industry is significantly driven by the rising incidence of gastrointestinal disorders, cancer, and other chronic conditions across the region, which continues to expand the patient population requiring diagnostic and therapeutic endoscopic procedures. According to Eurostat, in 2023, cancer was the second leading cause of death in the European Union, accounting for 1.16 million deaths and 23.9% of total deaths, highlighting the substantial disease burden across the region. This growing prevalence of oncology and gastrointestinal conditions is increasing the demand for procedures such as colonoscopy, gastroscopy, and endoscopic ultrasound, supporting early detection, disease staging, and minimally invasive treatment. The need for advanced diagnostic capabilities is further reinforcing the adoption of technologically enhanced endoscopic systems across European healthcare settings.

• Furthermore, increasing emphasis on early diagnosis and preventive healthcare continues to support the sustained utilization of endoscopy procedures across Europe. Government‑backed cancer screening programs, particularly for colorectal cancer, are driving routine endoscopic evaluations and contributing to consistent procedural volumes. Additionally, the presence of well-developed healthcare infrastructure, standardized clinical guidelines, and strong regulatory frameworks supports the integration of advanced technologies such as high‑definition imaging and AI‑assisted detection. Rising healthcare awareness, aging population trends, and expanding access to minimally invasive procedures are further strengthening the demand for endoscopic solutions, thereby reinforcing overall market growth across Europe.

Asia Pacific Endoscopy Market

The Asia Pacific endoscopy industry accounted for a substantial share of the market and was valued at USD 7.7 billion in 2025.

• The Asia Pacific endoscopy industry is significantly driven by the rapidly expanding aging population across the region, which is contributing to a higher burden of chronic and age‑related diseases requiring endoscopic diagnosis and treatment. According to the Economic and Social Commission for Asia and the Pacific, 670 million people aged 60 years and above were living in the region in 2022, representing approximately one in every seven individuals, and this number is projected to double to 1.3 billion by 2050, or one in four people. This demographic shift is substantially increasing the need for endoscopic procedures, particularly for gastrointestinal disorders, cancer screening, and other chronic conditions associated with aging, thereby supporting sustained market growth.

• Furthermore, the expanding healthcare infrastructure and increasing accessibility to diagnostic services across emerging economies continue to strengthen procedure volumes in the region. Growing investments in healthcare facilities, rising awareness of early disease detection, and improvements in endoscopy adoption across both urban and semi‑urban settings are contributing to increased utilization of minimally invasive procedures. Additionally, the rising burden of lifestyle‑related conditions, combined with improving affordability of medical technologies and the gradual expansion of advanced endoscopic systems, is reinforcing the demand for diagnostic and therapeutic endoscopy solutions across the Asia Pacific market.

Latin America Endoscopy Market

The Latin America endoscopy industry is anticipated to exhibit remarkable growth during the analysis period.

• The Latin America endoscopy industry is significantly driven by increasing government initiatives aimed at improving early detection of cancers, particularly colorectal and gastric cancers, across the region. Public healthcare systems, especially in countries such as Brazil, are enhancing access to diagnostic services through national programs and expansion of hospital-based endoscopy infrastructure.
• Governments across Latin America, particularly Brazil, are implementing national healthcare initiatives aimed at improving early detection of cancers such as colorectal and gastric cancer. Public healthcare systems are increasingly prioritizing the expansion of diagnostic infrastructure, leading to improved access to endoscopic procedures across urban and semi‑urban hospitals. In addition, public‑private collaborations are helping bridge gaps in equipment availability and service delivery, strengthening the overall capacity for endoscopic diagnostics. This growing emphasis on preventive healthcare and early‑stage disease identification is supporting the sustained demand for endoscopy services across the region.
• Furthermore, rapid urbanization across Latin America is contributing to significant lifestyle changes, including increased sedentary behavior, which is driving a rise in obesity, diabetes, and digestive disorders. The growing incidence of conditions such as gastroesophageal reflux disease (GERD), fatty liver disease, and colorectal disorders is increasing the need for gastrointestinal endoscopic procedures. This evolving disease profile is contributing to higher procedure volumes in hospitals and outpatient centers, while increasing focus from healthcare systems on managing chronic lifestyle‑related diseases is further supporting the utilization of endoscopy for screening, diagnosis, and treatment across the Latin America market.

Middle East and Africa Endoscopy Market

The Middle East and Africa endoscopy industry is expected to experience substantial growth over the analysis timeframe.

• The Middle East and Africa (MEA) endoscopy industry is gaining momentum due to expanding healthcare transformation initiatives aimed at strengthening diagnostic capabilities and modernizing care delivery systems. Strategic government programs, particularly in Gulf countries, are prioritizing infrastructure development, deployment of advanced diagnostic technologies, and adoption of minimally invasive procedures. The establishment of specialized medical facilities, along with increased participation from private healthcare providers and international collaborations, is enhancing access to endoscopic services and supporting market expansion across the region.

• Additionally, growing emphasis on clinical training and technical upskilling is contributing to the broader adoption of endoscopic procedures. Collaborative programs with global healthcare institutions facilitate knowledge transfer, improving procedural expertise, and enabling the use of advanced endoscopic techniques in routine practice. As the availability of trained professionals increases, healthcare systems are witnessing higher procedural efficiency and improved care quality. Continued focus on standardization of clinical practices and capacity building is further strengthening confidence in endoscopy utilization, thereby supporting sustained growth across the MEA market.

Endoscopy Market Share

• The endoscopy industry is highly dynamic, with key players such as Olympus Corporation, Stryker Corporation, Karl Storz, Boston Scientific, and Medtronic, which collectively account for 45% share of the global market.

• Leading players in the endoscopy industry are actively expanding their geographic footprint and strengthening distribution networks to enhance market penetration and accessibility. Strategic collaborations with hospitals, ambulatory surgical centers, and regional distributors, along with targeted acquisitions, are enabling companies to broaden their product portfolios and improve service delivery across both developed and emerging regions. These initiatives are critical for addressing rising procedural demand and ensuring availability of advanced endoscopic systems in diverse healthcare settings.
• For instance, companies such as Olympus Corporation and Medtronic have focused on expanding their imaging and visualization capabilities through strategic partnerships and continuous product innovation, while Boston Scientific and Ambu have strengthened their position by advancing single‑use endoscope portfolios and scaling manufacturing capabilities. These efforts support improved supply chain efficiency, enhance responsiveness to clinical demand, and enable companies to address the growing need for infection‑controlled and minimally invasive diagnostic solutions globally.
• Furthermore, market participants are increasingly aligning their strategies with evolving healthcare needs, including the rising demand for minimally invasive procedures, patient safety, and workflow efficiency. The integration of endoscopic systems with digital platforms, artificial intelligence‑assisted diagnostics, and specialized therapeutic tools is enabling more precise and efficient clinical interventions. In addition, increasing emphasis on sustainability, cost optimization, and reduction of reprocessing requirements is influencing product development, particularly in the shift toward disposable and hybrid endoscopic systems.
• Collectively, these strategic initiatives by leading players are redefining competitive dynamics, accelerating technology adoption, and supporting the long‑term growth trajectory of the endoscopy industry.

Endoscopy Market Companies

A few of the prominent players operating in the endoscopy industry include:

• B Braun
• Boston Scientific
• CONMED
• COOK MEDICAL
• FUJIFILM
• HOYA
• INTUITIVE
• Johnson & Johnson
• KARL STORZ
• Medtronic
• OLYMPUS
• RICHARD WOLF
• Smith & Nephew
• Stryker

• Boston Scientific

Boston Scientific is a key participant in the endoscopy industry, with a strong focus on advancing minimally invasive diagnostic and therapeutic solutions across gastrointestinal, pulmonary, and urological applications. The company has established a solid presence through its comprehensive portfolio of endoscopic devices, including the EXALT single‑use endoscope platform, which addresses critical challenges related to infection control and reprocessing.

• OLYMPUS

OLYMPUS dominates the endoscopy industry by utilizing modern imaging technologies such as 4K Ultra HD and Narrow Band Imaging (NBI), which enhance diagnostics further. Their trust as a global leader comes from their wide range of endoscopic tools combined with their focus on innovation.

• KARL STORZ

Karl Storz focuses on the development of premium rigid endoscopes and flexible endoscopes. Niche-specialized, precise, and robust engineering underline a certain level of flexibility and usage in numerous medical specialties.

Endoscopy Industry News:

• In April 2024, Ambu obtained 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its next-generation duodenoscopy solution, the aScope Duodeno 2 and aBox 2, designed for endoscopic retrograde cholangiopancreatography (ERCP) procedures. This approval is expected to enhance the company’s product range, enable a broader customer base and strengthen its market positioning.
• In April 2022, Laborie Medical Technologies Corp. announced that it has completed the acquisition of GI Supply, a leader in specialty endoscopy and paracentesis products for gastroenterologists, colorectal surgeons, and interventional radiologists. This acquisition enabled the company to expand its product portfolio and enabled a bigger customer base.

The endoscopy market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Market, By Product

• Endoscopes
  • Rigid endoscopes
  • Flexible endoscopes
  • Capsule endoscopes
• Visualization systems
• Endoscopic ultrasound
• Insufflator
• Other products

Market, By Application

• Laparoscopy
• GI endoscopy
  • Gastroscopy
  • Colonoscopy
  • Sigmoidoscopy
  • Duodenoscopy
  • Other GI endoscopies
• Arthroscopy
• ENT endoscopy
• Pulmonary endoscopy
• Obstetrics/Gynecology
• Other applications

Market, By Usability

• Reusable endoscope
• Single-use endoscope

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE